Close

SIRO Clinpharm partners with ACROSS Global Alliance; aims to bridge the gap in the pharmaceutical service provider market

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap in the pharmaceutical service provider market. ACROSS is a global alliance of clinical research organizations (CRO’s) also known as Partners along with special service providers known as Qualified Vendors. The Partners form the core of the ACROSS organization. SIRO Clinpharm will have the opportunity to provide its core services and expertise in India’s geography.

Commenting on this partnership, Karan Daftary, Director, SIRO Clinpharm said, “The relationship provides mutually beneficial outcomes for both parties, with SIRO Clinpharm having the opportunity to assist ACROSS’s clients in India, whilst ACROSS and its Partners can assist Siro Clinpharm’s clients with their overseas (i.e., outside India) clinical expertise in over 96 countries worldwide. This partnership opportunity enables Siro Clinpharm to actively participate in Global Clinical trials, where India is one of the regions that would be covered, in collaboration with other ACROSS Partners.”

The ACROSS Partnership model mimics the success of the multiple airline industry alliances, with ACROSS being a focused, central coordinating body that oversees the conduct of seamless global clinical trials with minimal overheads, thus passing on cost-effective solutions to the benefit of its clients.

“ACROSS was keen to strengthen its presence in the Indian market and after careful analysis of the CROs operating in the Indian market, comprehensive due diligence, and a full assessment of service offerings, SIRO Clinpharm was identified as a perfect fit for its expansion in India,” said Steven Bukvic, CEO for ACROSS Global. “SIRO Clinpharm has a well-established team of professional experts with a dynamic and forward-looking mindset that compliments ACROSS’s approach to the global pharmaceutical service provider market”.

Their comprehensive expertise and unique services will benefit the clients and strengthen ACROSS’s presence in India. With a seasoned team of more than 200 professionals from science and medical backgrounds, SIRO Clinpharm will also actively participate in global studies by offering their knowledge in the pharmaceutical, FMCG, and medical device industries. ACROSS has a well-defined process for the onboarding of Partners and Qualified Vendors along with a robust quality management system to ensure smooth conduct of studies. By being a Partner of ACROSS, Siro Clinpharm is ready to provide diversified high-quality, state-of-the-art services for clinical trials.

Latest stories